Slides presented by Dr. Marc Gastonguay at ACoP8 can be found here.
Slides available: Neighbor’s Envy Owner’s Pride – Comparator Analysis for Drug Development and Market Access
Modeling methods for analyzing tumor dynamic data from basket trials
Poster presented by Alanna S. Ocampo-Pelland and Jonathan L. French at ACoP8. See the poster here.
Topics: Methodology, Tools, and Computation, Oncology, Open Science
Gaining Efficiency by Combining Analytical and Numerical Methods to Solve ODEs: Implementation in Stan and Application to Bayesian PK/PD Modeling
Topics: Open Science
Slides available: Points to Consider when Making Inferences about Covariates
Topics: Open Science
Theory, Empiricism, and a Vision for the Continued Growth of Pharmacometrics
Slides Available: Dr. Marc Gastonguay's Sheiner Award lecture presented at ACoP8 on October 15, 2017. GastonguayISoPSheinerLecture2017final
Topics: Open Science
Developing quantitative systems pharmacology (QSP) models is hard work, without doubt. Such projects often take months, if not years, and may include extensive experimental contributions and input from numerous discipline experts.
Topics: Open Science
Metrum Research Group Recipient of Marcum Tech Top 40 Award; Tenth Annual Event to Honor Metrum Research Group as one of 40 Fastest Growing Tech Companies
Tariffville, CT (August 25, 2017) - The Connecticut Technology Council (CTC) and Marcum LLP announced Metrum Research Group has made the Marcum Tech Top 40 (TT40) list of fastest growing technology companies in Connecticut. Metrum Research Group will be honored alongside 39 other TT40 companies at an awards ceremony on September 19th at the Oakdale Theatre in Wallingford. This marks the seventh time Metrum Research Group has been honored to be a Marcum Tech Top 40 recipient.
Topics: Metrum News
Metrum Research Group Announces New President
Metrum Research Group is pleased to announce the appointment of Bill Knebel, Pharm.D., Ph.D. as President of the biomedical modeling and simulation services firm.
Topics: Metrum News
by Tim Bergsma
Already widely received in the finance community, cloud computing is gaining acceptance in the pharmaceutical industry as well. At this year’s American Conference on Pharmacometrics, Metrum Research Group staff presented a poster on the topic, and helped lead a related panel discussion.
“Prevention … we have never uttered that word at the Alzheimer’s Association International Conference, and here we actually highlighted three clinical trials in the planning for prevention of Alzheimer’s … “. This comment from Dr. Mario Carrillo gives voice to the enthusiasm and interest of the attendees at the standing-room-only Alzheimer’s Association International Conference session entitled, “Collaboration for Alzheimer’s Prevention: Common Issues Across Presymptomatic Treatment Trials”, in which the A4, API, and DIAN prevention trials were discussed.
Topics: Neurodegenerative Diseases
